Biological agents may be better sooner, rather than later, in moderate-to-severe Crohn's disease

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 5, 2007-05 ,pp. : 15-18

Adis International

Access to resources Recommend Favorite

Pharmacological treatment in moderate-to-severe Alzheimer's disease

By Hsiung Ging-Yuek Robin   Feldman Howard H  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2575-2582

Informa Healthcare

Access to resources Recommend Favorite

Peacekeeping in Crohn's disease: maintenance of remission

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 3, 2005-03 ,pp. : 7-11

Adis International

Access to resources Recommend Favorite

Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan

By Nakamura Yu   Kitamura Shin   Homma Akira   Shiosakai Kazuhito   Matsui Daiju  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 913-925

Informa Healthcare

Access to resources Recommend Favorite

Memantine: A Pharmacoeconomic Review of its Use in Moderate-to-Severe Alzheimer's Disease

By Plosker Greg L.   Lyseng-Williamson Katherine A.  

PharmacoEconomics, Vol. 23, Iss. 2, 2005-01 ,pp. : 193-206

Adis International

Access to resources Recommend Favorite